These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10468735)

  • 1. MUC1 mucin as a tumour marker in bladder cancer.
    Simms MS; Hughes OD; Limb M; Price MR; Bishop MC
    BJU Int; 1999 Aug; 84(3):350-2. PubMed ID: 10468735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucin expression by transitional cell carcinomas of the bladder.
    Walsh MD; Hohn BG; Thong W; Devine PL; Gardiner RA; Samaratunga ML; McGuckin MA
    Br J Urol; 1994 Mar; 73(3):256-62. PubMed ID: 8162502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
    Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
    J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection.
    Varela JC; Atkinson C; Woolson R; Keane TE; Tomlinson S
    Int J Cancer; 2008 Sep; 123(6):1357-63. PubMed ID: 18561323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of transurethral resection of bladder tumour on serum levels of soluble E-cadherin.
    Durkan GC; Brotherick I; Mellon JK
    BJU Int; 1999 Mar; 83(4):424-8. PubMed ID: 10210565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verification of WFA-Sialylated MUC1 as a Sensitive Biliary Biomarker for Human Biliary Tract Cancer.
    Yamaguchi T; Yokoyama Y; Ebata T; Matsuda A; Kuno A; Ikehara Y; Shoda J; Narimatsu H; Nagino M
    Ann Surg Oncol; 2016 Feb; 23(2):671-7. PubMed ID: 26416714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of serum lipid-bound sialic acid in bladder tumours.
    Oztokatli A; Ozkardeş H; Ovül E; Erol D
    Int Urol Nephrol; 1992; 24(2):125-9. PubMed ID: 1624255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of nuclear matrix protein 22 as a tumour marker in the detection of transitional cell carcinoma of the bladder.
    Sánchez-Carbayo M; Herrero E; Megías J; Mira A; Soria F
    BJU Int; 1999 Oct; 84(6):706-13. PubMed ID: 10510120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
    Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
    J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder.
    Bhagirath D; Abrol N; Khan R; Sharma M; Seth A; Sharma A
    Clin Chim Acta; 2012 Oct; 413(19-20):1641-6. PubMed ID: 22626996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging for staging bladder cancer: a clinical study of intravenous 111indium-labelled anti-MUC1 mucin monoclonal antibody C595.
    Hughes OD; Perkins AC; Frier M; Wastie ML; Denton G; Price MR; Denley H; Bishop MC
    BJU Int; 2001 Jan; 87(1):39-46. PubMed ID: 11121991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of mucin 1 possessing a 3'-sulfated core1 in recurrent and metastatic breast cancer.
    Ideo H; Hinoda Y; Sakai K; Hoshi I; Yamamoto S; Oka M; Maeda K; Maeda N; Hazama S; Amano J; Yamashita K
    Int J Cancer; 2015 Oct; 137(7):1652-60. PubMed ID: 25787775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of serum laminin P1 in the diagnosis of transitional cell carcinoma of the bladder.
    Abou Farha KM; Menheere PP; Bruins JL; Kester AD; Janknegt R
    Eur Urol; 1992; 21(3):240-4. PubMed ID: 1499633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of MUC1 in sera of ovarian cancer patients and in sera of patients with benign changes of the ovaries with CA15-3, CA27.29, and PankoMab.
    Jeschke U; Wiest I; Schumacher AL; Kupka M; Rack B; Stahn R; Karsten U; Mayr D; Friese K; Dian D
    Anticancer Res; 2012 May; 32(5):2185-9. PubMed ID: 22593508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.
    Feil G; Zumbrägel A; Päulgen-Nelde HJ; Hennenlotter J; Maurer S; Krause S; Bichler KH; Stenzl A
    Anticancer Res; 2003; 23(2A):963-7. PubMed ID: 12820331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ploidy and Tn-antigen expression in the detection of transitional cell neoplasia in non-tumour-bearing patients.
    Pinnock CB; Roxby DJ; Ross JM; Pozza CH; Marshall VR
    Br J Urol; 1995 Apr; 75(4):461-9. PubMed ID: 7788257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue and serum MUC1 mucin detection in breast cancer patients.
    Croce MV; Isla-Larrain MT; Demichelis SO; Gori JR; Price MR; Segal-Eiras A
    Breast Cancer Res Treat; 2003 Oct; 81(3):195-207. PubMed ID: 14620915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chorionic gonadotropin beta-subunit and core fragment in bladder cancer: mRNA and protein expression in urine, serum and tissue.
    Hotakainen K; Haglund C; Paju A; Nordling S; Alfthan H; Rintala E; Stenman UH
    Eur Urol; 2002 Jun; 41(6):677-85. PubMed ID: 12074787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancer.
    Hughes OD; Bishop MC; Perkins AC; Frier M; Price MR; Denton G; Smith A; Rutherford R; Schubiger PA
    Eur J Nucl Med; 1997 Apr; 24(4):439-43. PubMed ID: 9096097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of a diagnostic score for colon cancer based on serum CEA, CA19-9, cytokeratin-1 and mucin-1.
    Attallah AM; El-Far M; Ibrahim AR; El-Desouky MA; Omran MM; Elbendary MS; Attallah KA; Qura ER; Abdallah SO
    Br J Biomed Sci; 2018 Jul; 75(3):122-127. PubMed ID: 29734875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.